Clinical Trial Update: Utility of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Predicting Renal Impairment, Further Decompensation and Rehospitalization in Acutely Decompensated and Chronic Heart Failure Patients

View source ↗

Summary

A completed clinical trial evaluating whether the biomarker NGAL can predict renal impairment, further decompensation, and rehospitalization in patients with ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure
• Heart Failure

Snippet

Sponsor: The Alfred | Conditions: Heart Failure | Status: COMPLETED